levofloxacin has been researched along with Primary Peritonitis in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukuda, H; Fukuda, S; Irie, M; Kunimoto, H; Morihara, D; Sakisaka, S; Shakado, S; Takata, K; Takeyama, Y; Tanaka, T; Umeda, K; Yamauchi, R; Yokoyama, K | 1 |
Aly, TF; Badawy, AA; Emara, MH; Shaheen, NE; Sharaf, SM; Zaher, TI | 1 |
Chen, Y; Ding, X; Gu, H; Guo, M; Guo, X; Wang, Y; Zhang, Y | 1 |
Gregory, J; Huesmann, G; Jakoby, MG; Vallurupalli, S | 1 |
Alişkan, H; Güçlü, M; Husamettin, E; Serin, E; Yakar, T | 1 |
Chen, X; Guo, X; Shi, G; Wang, H; Wang, S; Zhang, X | 1 |
Ascione, T; Esposito, S; Gaeta, GB; Ianniello, F; Leone, S; Noviello, S | 1 |
Shinagawa, N; Takeyama, H; Taniguchi, M; Yura, J | 1 |
Abraham, J; Jacob, JJ; Kapoor, R; Singh, M | 1 |
Cormican, MG; Jones, RN; Runyon, BA | 1 |
1 review(s) available for levofloxacin and Primary Peritonitis
Article | Year |
---|---|
Fitz-Hugh-Curtis syndrome in a man positive for Chlamydia trachomatis.
Topics: Abdominal Pain; Anti-Bacterial Agents; Anti-Ulcer Agents; Chlamydia Infections; Chlamydia trachomatis; Drug Therapy, Combination; Duodenal Ulcer; Hepatitis; Humans; Levofloxacin; Male; Middle Aged; Omeprazole; Pelvic Inflammatory Disease; Peritonitis; Urine | 2018 |
1 trial(s) available for levofloxacin and Primary Peritonitis
Article | Year |
---|---|
Effect of alternative antibiotics in treatment of cefotaxime resistant spontaneous bacterial peritonitis.
Topics: Adult; Anti-Bacterial Agents; Ascitic Fluid; Cefotaxime; Chi-Square Distribution; Drug Resistance, Bacterial; Drug Substitution; Egypt; Female; Humans; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Peritonitis; Predictive Value of Tests; Prospective Studies; Thienamycins; Time Factors; Treatment Outcome | 2013 |
8 other study(ies) available for levofloxacin and Primary Peritonitis
Article | Year |
---|---|
Antibiotic-loaded, silver core-embedded mesoporous silica nanovehicles as a synergistic antibacterial agent for the treatment of drug-resistant infections.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Mice, Inbred BALB C; Nanocapsules; Peritonitis; Silicon Dioxide; Silver | 2016 |
Levofloxacin-associated hypoglycaemia complicated by pontine myelinolysis and quadriplegia.
Topics: Anti-Bacterial Agents; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Hypoglycemia; Kidney Neoplasms; Levofloxacin; Liposarcoma; Male; Middle Aged; Myelinolysis, Central Pontine; Ofloxacin; Peritonitis; Postoperative Complications; Quadriplegia | 2008 |
A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Cefepime; Cefotaxime; Cephalosporins; Drug Resistance, Bacterial; Enterococcus; Escherichia coli Infections; Female; Humans; Infusions, Intravenous; Klebsiella Infections; Klebsiella pneumoniae; Leukocyte Count; Levofloxacin; Liver Cirrhosis; Male; Microbial Sensitivity Tests; Middle Aged; Neutrophils; Ofloxacin; Peritonitis; Pneumococcal Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections | 2010 |
Activity of sitafloxacin against extracellular and intracellular Staphylococcus aureus in vitro and in vivo: comparison with levofloxacin and moxifloxacin.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Cell Line; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Space; Fluoroquinolones; Intracellular Space; Levofloxacin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Peritonitis; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 2012 |
Clinical efficacy and tolerability of levofloxacin in patients with liver disease: a prospective, non comparative, observational study.
Topics: Administration, Oral; Anti-Bacterial Agents; Chronic Disease; Drug Tolerance; Female; Humans; Levofloxacin; Liver Diseases; Male; Middle Aged; Ofloxacin; Peritonitis; Pneumonia; Prospective Studies; Urinary Tract Infections | 2006 |
[Bilophila wadsworthia isolated from surgical specimens].
Topics: Anti-Bacterial Agents; beta-Lactams; Bilophila; Ciprofloxacin; Clindamycin; Digestive System Surgical Procedures; Drug Resistance, Bacterial; Humans; Japan; Levofloxacin; Minocycline; Ofloxacin; Peritonitis; Postoperative Complications; Specimen Handling; Surgical Wound Infection | 2006 |
Fatal hypoglycemia with levofloxacin use in an elderly patient in the post-operative period.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Duodenal Ulcer; Fatal Outcome; Humans; Hyperinsulinism; Hypoglycemia; Infusions, Intravenous; Levofloxacin; Male; Ofloxacin; Peptic Ulcer Perforation; Peritonitis; Postoperative Care; Postoperative Complications; Recurrence | 2008 |
In vitro activity of levofloxacin and FK-037 against aerobic isolates from spontaneous bacterial peritonitis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria, Aerobic; Ceftizoxime; Enterobacteriaceae; Humans; Isomerism; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Peritonitis; Streptococcus | 1995 |